This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignee: Pierre Fabre Medicament. Active years: 2013-2015.
Company Filing History:
Years Active: 2013-2015
Title: Karine Valeille: Innovator in Human Therapeutics
Introduction
Karine Valeille is a prominent inventor based in Palaiseau, France. She has made significant contributions to the field of human therapeutics, particularly through her innovative research and development of novel compounds.
Latest Patents
Valeille holds 3 patents that focus on the development of nitrogen heterocycle derivatives and their applications in treating various health conditions. Her latest patents include:
1. Nitrogen heterocycle derivatives, preparation thereof and application thereof in human therapeutics. This invention relates to compounds characterized by a general formula that showcases their potential in therapeutic applications.
2. Derivatives of 2H pyridazin-3-ones, their preparation and their use as SCD-1 inhibitors. This patent concerns compounds that are designed to inhibit the SCD-1 enzyme, which is crucial for the treatment of obesity, type-2 diabetes, and lipid disorders.
Career Highlights
Karine Valeille is currently employed at Pierre Fabre Medicament, where she continues to advance her research in pharmaceutical innovations. Her work has been instrumental in developing new therapeutic strategies that address significant health challenges.
Collaborations
Valeille collaborates with esteemed colleagues such as Elisabeth Dupont-Passelaigue and Didier Junquero. These partnerships enhance her research efforts and contribute to the success of her innovative projects.
Conclusion
Karine Valeille is a dedicated inventor whose work in human therapeutics is paving the way for new treatments. Her patents reflect her commitment to addressing critical health issues through innovative solutions.